Day: May 20, 2021

On 19 May 2021 the amended Articles of Association of Grigeo AB (hereinafter – the Company) were registered in the Register of Legal Entities. The Articles of Association were amended following the decision of the Annual General Meeting of Shareholders of the Company of 30 April 2021 to increase the authorised capital of the Company    out of the Company’s funds from EUR 19,053,000 to EUR 38,106,000 by issuing 65,700,000 ordinary registered shares with a nominal value of EUR 0.29. In the coming days the shareholders shall receive new ordinary shares with a nominal value of EUR 0.29 for no consideration, with the number of the shares to be in proportion to the nominal value of the shares owned by them at the close of the rights accounting day (14 May 2021) of the Company’s Annual General Meeting of Shareholders of 30 April 2021. The Company...

                FOR IMMEDIATE RELEASE May 19, 2021 SOCIÉTÉ BIC Annual General Meetingand Board of DirectorsPayment of 1.80 euros ordinary dividend per share Clichy, France, May 20, 2021 – SOCIÉTÉ BIC’s Annual General Meeting was held on Wednesday, May 19, 2021, in Paris, behind closed doors and broadcasted live in video format to protect the health and safety of all stakeholders due to the ongoing pandemic. A replay of the event and presentations are available on BIC’s website. Chaired by Pierre Vareille, Chairman of the Board, the meeting was also attended in person by Gonzalve Bich, Chief Executive Officer and John Glen, Director. All other Board members attended via video conference. All the proposed resolutions were approved and included the following: Ordinary Shareholders‘ meetingapproval of the Financial Statements...

Convening Notice of General Meeting of Holders of Covered Bonds Issued by BCP, SAAttachmentConvocatoria OH EN

GOGL – First Quarter 2021 Results Golden Ocean Group Limited (NASDAQ: GOGL / OSE: GOGL) (the “Company” or “Golden Ocean”), a leading dry bulk shipping company, today announced its results for the quarter ended March 31, 2021. HighlightsNet income of $23.6 million and earnings per share of $0.14 for the first quarter of 2021, the best first quarter result in the history of the Company, compared with net income of $25.4 million and earnings per share of $0.18 for the fourth quarter of 2020. Adjusted EBITDA of $54.6 million for the first quarter of 2021, compared with $59.3 million for the fourth quarter of 2020. Reported TCE rates for Capesize and Panamax/Ultramax vessels of $16,611 per day and $14,777 per day, respectively, in the first quarter of 2021. Reported TCE rate for the whole fleet of $15,886 per day. Entered into a Heads of...

The shares purchased by DNB on behalf of Equinor (OSE: EQNR, NYSE: EQNR) on 14 May 2021 for use in the group’s share saving plan have on 20 May 2021 been distributed to the employees in accordance with their savings amount. Following this, the share saving plan has 10,393,765 shares. This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act

Seneca Growth Capital VCT Plc 20 May 2021 Extension of Offer         On 13 October 2020 Seneca Growth Capital VCT Plc (the “Company”) launched an offer for subscription for B shares to raise, in aggregate, up to £10 million with an over-allotment facility of up to a further £10 million (before issue costs) (the “Offer”). Full details of the Offer are contained in a prospectus issued by the Company on that date (the “Prospectus”). Pursuant to the terms and conditions of the Offer set out in the Prospectus, the Offer may be extended by the Directors at their absolute discretion to a date no later than 24 September 2021. Accordingly, the Directors of the Company have agreed to extend the closing date of the Offer from 5.00 p.m. 28 May 2021 to 5.00 p.m. 24 September 2021, unless previously fully subscribed...

Today, the Board of Directors of The Drilling Company of 1972 A/S (“Maersk Drilling”) has adopted the trading statement for the first quarter of 2021 (Q1 2021): Performance highlights for Q1 2021 (Q4 2020 in brackets)Revenue of USD 264m (USD 286m) Contracted days were 1,199 (1,204) resulting in a utilisation of 61% (59%) Average day rate excluding one-offs of USD 217k (USD 221k) Financial uptime of 92.9% (98.9%) Secured contracts with a total contract value of USD 730m (USD 65m) Revenue backlog of USD 1.8bn at 31 March 2021 (USD 1.3bn at 31 December 2020). Forward contract coverage for the remainder of 2021 of 64% and 24% for 2022.Guidance for 2021The full-year guidance for 2021 was revised on 19 May 2021 as follows:•    Profit before depreciation and amortisation, impairment losses/reversals and special items (EBITDA before special...

By the decision of the Financial and Capital Market Commission of April 13, 2021, Duke I S.à r.l. (a private limited company entered on the Trade and Companies Register of the Grand Duchy of Luxembourg, registration number B247170, registered office at 11-13 Boulevard de la Foire, L-1528 Luxembourg, Grand Duchy of Luxembourg) was authorized to make a mandatory buyout offer to the shareholders of the joint-stock company „VALMIERAS STIKLA ŠĶIEDRA” (registration number: 40003031676, registered address: Cempu iela 13, Valmiera, LV-4201, Latvija) pursuant to the article 66 section 4 subsections 1) and 2) of the Financial Instruments Market Law. The mandatory buyout offer closed on May 17, 2021 (16:00 GMT + 2). THE RESULTS OF BUYOUT OFFER: Number of shares offered for saleWithin the framework of the mandatory share buyout offer, it was offered...

Tecentriq improved disease-free survival by more than one-third in people with PD-L1-positive resectable early-stage lung cancer, compared with best supportive care First and only cancer immunotherapy to show positive Phase III results in the adjuvant lung cancer setting New adjuvant treatment options are urgently needed in early lung cancer to help the approximately 50% of people who currently experience recurrence following surgeryBasel, 20 May 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced interim results from the Phase III IMpower010 study, showing for the first time that treatment with Tecentriq® (atezolizumab) following surgery and chemotherapy reduced the risk of disease recurrence or death (disease-free survival; DFS) by 34% (hazard ratio [HR]=0.66, 95% CI: 0.50–0.88) in people with Stage II-IIIA non-small cell lung...

  PRESS RELEASEParis, May 20, 2021, 7am CET2021 FIRST-QUARTER BUSINESS For the first quarter of 2021, the Parrot Group is reporting consolidated revenues of €12.4m. The American subsidiary specialized in precision farming sensors (Micasense), sold on January 27, 2021, is no longer consolidated from the first quarter of 2021 and its revenues have been eliminated from 2020 to obtain a comparable basis. The realignment around commercial drones is delivering a range of benefits: at constant exchange rates, Group revenues (comparable basis) are up 6.5% (stable at current exchange rates) compared with the first quarter of 2020. Over the period, the Group’s commercial development was marked by:The 50.5% increase in revenues for micro-drones (+56.9% at current exchange rates) to €4.8m, driven by strong sales growth for commercial micro-drones...